Make Pharmaceutical firms help users who want to stop taking anxiety & depression drugs
Pharmaceutical companies: Create tapering kits to help users who want to stop taking prescription drugs for anxiety and depression Psychoactive prescription drugs (such as antidepressants, antipsychotics and anti-anxiety medications) are often very difficult to stop taking. Many people experience difficulties stopping or reducing their drugs even with the support of Doctors and Psychiatrists. Because stopping or reducing these drugs is so difficult, many people feel trapped into taking these tablets for many years, giving them side effects and costing the NHS money in providing unnecessary prescriptions. Many of these drugs cause a physical dependance and the best way to avoid any unpleasant symptoms is to reduce the dosage slowly over an extended period. As it is now, many people who want to stop have no option but to reduce to the lowest possible dosage then “jump off” which can be extremely challenging. Some users simply carry on taking a drug beyond the point at which it was effective and useful to avoid the challenge of stopping. Listen to the New podcast: On iTunes Let's Talk Withdrawal podcast Or via my website Let's Talk Withdrawal podcast What we want We want the Pharmaceutical manufacturers to produce “drug tapering kits” which provide the most commonly prescribed medications in decreasing doses over a period of time. We need tapering kits to help the millions of users of psychoactive pharmaceutical drugs because: Many tablets are only available in increments that are so large that they are useless for gradual lowering (tapering) of the dose. Liquid forms for some medications are available but tend to be hugely expensive and therefore the NHS will not provide them. Pill cutting is, at best, a hit and miss affair and can lead to withdrawal. Many doctors and psychiatrists confuse the symptoms of withdrawal with a return of the symptoms that the tablet was originally prescribed for. These kits would save a significant amount of time for General Practitioners, Psychiatrists and Community Mental Health teams. These kits would help users of psychiatric medications stop taking them safely and in a controlled fashion, giving them control over their drug intake. The pharmaceutical companies are already set up to manufacture massive quantities of these drugs, therefore it cannot be a huge additional cost to manufacture tablets of decreasing dosages. At most this is likely to be a tiny fraction of a percentage of profit but would win a huge amount of public confidence that the Pharmaceutical firms have their customers safety at heart.